Uncategorized
Lack of specifics on obesity pill sales hover over Lilly’s first quarter
Investors hoping for more accurate sales figures for Foundayo, Eli Lilly’s newly launched obesity pill, were disappointed Thursday when the company did not reveal them when it reported its first quarter financials.
Novo Nordisk, by …